Nucleome Therapeutics, a leading UK biotech firm that specialises in decoding the dark genome's non-coding DNA regions to develop precision medicines for autoimmune diseases like multiple sclerosis, lupus, and rheumatoid arthritis, purchase LTE research-grade autoclave to assist with research. Click to read more.
The University of Oxford has announced plans to establish a new Poonawalla Vaccines Research building with a funding commitment of GBP 50 million from India’s Serum Life Sciences. Serum Life Sciences is wholly-owned by the Poonawalla family, owners of the Adar Poonawalla-led Serum Institute of India, and the proposed research facility will focus on vaccinology,
Regius Professor of Medicine, Sir John Bell, to step down from Oxford role ox.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ox.ac.uk Daily Mail and Mail on Sunday newspapers.